A. E. Till

584 total citations
14 papers, 490 citations indexed

About

A. E. Till is a scholar working on Analytical Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, A. E. Till has authored 14 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Analytical Chemistry, 4 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in A. E. Till's work include Analytical Methods in Pharmaceuticals (5 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Potassium and Related Disorders (3 papers). A. E. Till is often cited by papers focused on Analytical Methods in Pharmaceuticals (5 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Potassium and Related Disorders (3 papers). A. E. Till collaborates with scholars based in United States, Germany and United Kingdom. A. E. Till's co-authors include M Hichens, HJ Gomez, E H Ulm, Elizabeth Hand, Jérôme Biollaz, John D. Irvin, Helen R. Skeggs, Peter H. Vlasses, Torbjørn Aarsland and Brian N. Swanson and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmacology and Experimental Therapeutics and Journal of Chromatography A.

In The Last Decade

A. E. Till

14 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. E. Till United States 12 174 144 99 77 73 14 490
David A Willard United States 11 190 1.1× 176 1.2× 62 0.6× 33 0.4× 77 1.1× 14 569
HJ Gomez United States 8 273 1.6× 142 1.0× 56 0.6× 79 1.0× 57 0.8× 9 494
Sampat M. Singhvi Malaysia 8 191 1.1× 187 1.3× 60 0.6× 31 0.4× 79 1.1× 12 544
DA Willard United States 13 140 0.8× 72 0.5× 118 1.2× 74 1.0× 91 1.2× 18 592
S. M. Singhvi United States 12 113 0.6× 108 0.8× 118 1.2× 75 1.0× 105 1.4× 24 632
HL Elliott United Kingdom 17 381 2.2× 186 1.3× 126 1.3× 197 2.6× 65 0.9× 57 876
Richard L. Lalonde United States 17 117 0.7× 106 0.7× 117 1.2× 80 1.0× 159 2.2× 32 695
D S Hewick United Kingdom 11 117 0.7× 140 1.0× 79 0.8× 35 0.5× 49 0.7× 32 641
G. Kaiser Switzerland 14 104 0.6× 61 0.4× 74 0.7× 135 1.8× 56 0.8× 20 451
James M. Jaffe United States 15 53 0.3× 192 1.3× 118 1.2× 89 1.2× 91 1.2× 46 785

Countries citing papers authored by A. E. Till

Since Specialization
Citations

This map shows the geographic impact of A. E. Till's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. E. Till with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. E. Till more than expected).

Fields of papers citing papers by A. E. Till

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. E. Till. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. E. Till. The network helps show where A. E. Till may publish in the future.

Co-authorship network of co-authors of A. E. Till

This figure shows the co-authorship network connecting the top 25 collaborators of A. E. Till. A scholar is included among the top collaborators of A. E. Till based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. E. Till. A. E. Till is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Halpin, Rita A., E H Ulm, A. E. Till, et al.. (1993). Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.. Drug Metabolism and Disposition. 21(6). 1003–1011. 47 indexed citations
2.
Till, A. E., et al.. (1989). The pharmacokinetics of lisinopril in hospitalized patients with congestive heart failure.. British Journal of Clinical Pharmacology. 27(2). 199–204. 19 indexed citations
3.
Alberts, Alfred W., J. S. Macdonald, A. E. Till, & Jonathan A. Tobert. (1989). Lovastatin. Cardiovascular Drug Reviews. 7(2). 89–109. 15 indexed citations
4.
Dickstein, Kenneth, A. E. Till, Torbjørn Aarsland, et al.. (1987). The pharmacokinetics of enalapril in hospitalized patients with congestive heart failure.. British Journal of Clinical Pharmacology. 23(4). 403–410. 36 indexed citations
5.
McNabb, W R, et al.. (1985). Effects of repeated doses of enalapril on renal function in man.. British Journal of Clinical Pharmacology. 19(3). 353–361. 18 indexed citations
6.
Löwenthal, David, John D. Irvin, Donna Merrill, et al.. (1985). The effect of renal function on enalapril kinetics. Clinical Pharmacology & Therapeutics. 38(6). 661–666. 36 indexed citations
7.
Swanson, Brian N., Peter H. Vlasses, R Ferguson, et al.. (1984). Influence of Food on the Bioavailability of Enalapril. Journal of Pharmaceutical Sciences. 73(11). 1655–1657. 47 indexed citations
8.
Irvin, John D., et al.. (1984). BIOAVAILABILITY OF ENALAPRIL MALEATE. 33. 248–252. 14 indexed citations
9.
Ulm, E H, M Hichens, HJ Gomez, et al.. (1982). Enalapril maleate and a lysine analogue (MK‐521): disposition in man.. British Journal of Clinical Pharmacology. 14(3). 357–362. 182 indexed citations
10.
Garzó, G., G. Alexander, & A. E. Till. (1980). Gas chromatographic determination of 5-alkyl-uracils and 5-alkyl-deoxyuridines using flash methylation and glass capillary columns. Journal of Chromatography A. 191. 253–260. 3 indexed citations
11.
Till, A. E. & Leslie Z. Benet. (1979). Renal excretion of pseudoephedrine in the rat.. Journal of Pharmacology and Experimental Therapeutics. 211(3). 555–560. 12 indexed citations
12.
Skeggs, Helen R., et al.. (1976). Comparative clinical pharmacology of intravenous cefoxitin and cephalothin. European Journal of Clinical Pharmacology. 9(5-6). 397–403. 19 indexed citations
13.
Hartmann, Ieneke J. C., et al.. (1975). Serum concentrations of ampicillin and probenecid and ampicillin excretion after repeated oral administration of a pivampicillin-probenecid salt (MK-356). European Journal of Clinical Pharmacology. 9(2-3). 125–129. 1 indexed citations
14.
Goodwin, C. S., et al.. (1974). Effects of Rate of Infusion and Probenecid on Serum Levels, Renal Excretion, and Tolerance of Intravenous Doses of Cefoxitin in Humans: Comparison with Cephalothin. Antimicrobial Agents and Chemotherapy. 6(3). 338–346. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026